Hemming et al., in 1993 conjugated a benzoporphyrin derivative (BPD) to tumor-specific anti-epidermal growth factor receptor (anti-EGFr) antibody (Hemming et al., 1993). The gene discussed is EGFR; the disease is neoplasm.